Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial
2015 · The Lancet Oncology · 293 citations
https://doi.org/10.1016/s1470-2045(14)71181-7
M
Min-Jung Lee
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
62
Papers
3.5K
Citations
31
h-index
44
i10-index
Min-Jung Lee is an academic researcher from Kangwon National University. The author has contributed to research in topics: dental development and anomalies & Histone Deacetylase Inhibitors Research & Cancer Immunotherapy and Biomarkers. The author has an h-index of 31, co-authored 53 publications.
Papers by this author
worksPhase I/II Study of the Mesothelin-targeted Immunotoxin LMB-100 with Nab-Paclitaxel for Patients with Advanced Pancreatic Adenocarcinoma
2019 · Clinical Cancer Research · 49 citations
https://doi.org/10.1158/1078-0432.ccr-19-2586
Shh and ROCK1 modulate the dynamic epithelial morphogenesis in circumvallate papilla development
2008 · Developmental Biology · 42 citations
https://doi.org/10.1016/j.ydbio.2008.10.034
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat